ONSTIN is a premium health and nutrition brand founded in 2016 in Maryland, USA, by Dr. Kanikkannan (a postdoctoral researcher from the University of Florida) in collaboration with Nutra Standard Inc., and is now a subsidiary of Nutra Standard Inc. Its core team consists of experts from top-tier institutions such as Harvard University and the University of Washington, including Nobel Prize laureates in Physiology or Medicine.

The brand entered the Chinese market in 2018, launching its first NMN capsules and continuously expanding its product line to include various forms such as capsules and gummies. In 2023, it introduced High end luxury care series products products like ONSTIN LAM+ and ONSTIN NAD25800.

ONSTIN is committed to using globally sourced premium ingredients, with a high proportion of raw materials from Utah ranches in the U.S., while also partnering with organic farms worldwide to ensure that over 80% of its products contain natural ingredients. The brand adheres to strict international standards such as GMP and FDA regulations, with formulas developed by professional R&D teams to deliver safe and effective nutritional solutions.

ONSTIN has earned 11 international certifications and multiple industry awards, receiving widespread recognition from over a hundred media outlets and beauty influencers. Positioned as a high-end brand, it primarily targets consumers aged 25+ with higher incomes. In China, it has accumulated over 5 million users, covering both online and offline channels (including more than 100 physical stores), with an over 35% repurchase rate on its official e-commerce platforms.

As its brand slogan goes: "ONSTIN – Your Nature Solution."